Synageva BioPharma (GEVA) to Present at Upcoming Investor Conferences
11/7/2012 10:03:38 AM
LEXINGTON, Mass.--(BUSINESS WIRE)--Synageva BioPharma Corp. (“Synageva”) (NASDAQ:GEVA), a clinical stage biopharmaceutical company developing therapeutic products for rare disorders, today announced that Sanj K. Patel, President and Chief Executive Officer, will present at the Jefferies 2012 Global Healthcare Conference in London, England on Wednesday, November 14th, 2012, at 10:00 a.m. GMT (5:00 a.m. EST). In addition, the company will host one-on-one meetings at the Leerink Swann Management Access Day on November 20, 2012 in Boston, MA.
comments powered by